- Home
- AVTX vs GMGI Comparison
AVTX vs GMGI Comparison
Compare AVTX & GMGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- GMGI
- Stock Information
- Founded
- AVTX 2011
- GMGI 2008
- Country
- AVTX United States
- GMGI United States
- Employees
- AVTX N/A
- GMGI N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- GMGI Computer Software: Prepackaged Software
- Sector
- AVTX Health Care
- GMGI Technology
- Exchange
- AVTX Nasdaq
- GMGI Nasdaq
- Market Cap
- AVTX 138.8M
- GMGI 142.5M
- IPO Year
- AVTX 2015
- GMGI N/A
- Fundamental
- Price
- AVTX $13.50
- GMGI $1.03
- Analyst Decision
- AVTX Strong Buy
- GMGI Strong Buy
- Analyst Count
- AVTX 9
- GMGI 1
- Target Price
- AVTX $30.14
- GMGI $4.00
- AVG Volume (30 Days)
- AVTX 451.4K
- GMGI 242.1K
- Earning Date
- AVTX 11-06-2025
- GMGI 11-12-2025
- Dividend Yield
- AVTX N/A
- GMGI N/A
- EPS Growth
- AVTX N/A
- GMGI N/A
- EPS
- AVTX N/A
- GMGI N/A
- Revenue
- AVTX $441,000.00
- GMGI $172,818,124.00
- Revenue This Year
- AVTX N/A
- GMGI $25.43
- Revenue Next Year
- AVTX N/A
- GMGI $13.00
- P/E Ratio
- AVTX N/A
- GMGI N/A
- Revenue Growth
- AVTX N/A
- GMGI 54.66
- 52 Week Low
- AVTX $3.39
- GMGI $0.91
- 52 Week High
- AVTX $16.00
- GMGI $3.06
- Technical
- Relative Strength Index (RSI)
- AVTX 65.78
- GMGI 38.89
- Support Level
- AVTX $12.41
- GMGI $1.06
- Resistance Level
- AVTX $14.73
- GMGI $1.16
- Average True Range (ATR)
- AVTX 0.94
- GMGI 0.09
- MACD
- AVTX 0.13
- GMGI 0.02
- Stochastic Oscillator
- AVTX 70.97
- GMGI 24.97
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.